Pfizer suffers late-stage cancer drug failures
March 12, 2010Research and Development Cancer, Pfizer, Sutent, figitumumab
Pfizer has suffered late-stage trial failures for Sutent and lung cancer candidate figitumumab. Kidney cancer drug Sutent (sunitinib) failed to …
Talking Point: Following transit and storage rules
March 12, 2010Manufacturing and Production NYK Logistics, Talking Point, logistics, supply chain, talking logistics
Most people involved in pharmaceuticals will be aware of the strict procedures that must be employed for product manufacture (Good …
GSK expands inflammatory alliance
March 12, 2010Research and Development Cellzome, GlaxoSmithKline, rheumatoid arthritis
GlaxoSmithKline has formed a second strategic alliance with Cellzome to research new treatments for inflammatory diseases. GSK will buy into …
Chinese API supplier warned by FDA over manipulated data
March 12, 2010Manufacturing and Production API, China, XiAn Libang Pharmaceutical, manufacturing quality
A Chinese manufacturer has been sent a warning letter by the US Food and Drug Administration after it emerged an …
NHS urged to make more of new patient experience data
March 12, 2010NHS, PROMs, hc, king's fund
Healthcare bosses and clinicians have been urged to make the most of new patient experience data. ‘Getting the most out …
AstraZeneca signs generics deal with Torrent
March 11, 2010AZ, generics
AstraZeneca have signed a license and supply agreement with Indian-based Torrent Pharma that will boost its generics portfolio. Torrent will …
Pfizer muscles in on Ratiopharm sale
March 11, 2010Sales and Marketing Pfizer, Ratiopharm, Teva, generics
Pfizer has reportedly bid $4 billion for German generics firm Ratiopharm in a bid to rapidly expands its portfolio in …
Teva appoints Dr Phillip Frost chairman
March 11, 2010Sales and Marketing Teva, appointment, sales and marketing
Teva Pharmaceutical Industries has appointed Dr Phillip Frost as chairman of the board of directors. His appointment is part of …
Novartis buys into Transgene’s lung cancer candidate
March 11, 2010Research and Development Novartis, Transgene, immunotherapy, lung cancer
French biotech company Transgene has signed a deal with Novartis for the future development and marketing of its potential lung …
Investments boost Irish pharma sector
March 11, 2010Research and Development, Sales and Marketing Ireland, PPD, Warner Chilcott
Contract research organisation PPD has officially opened its new research laboratory in Athlone, Ireland, and started recruiting for the first …
German Health Minister attacks ‘pharma monopoly’
March 10, 2010Sales and Marketing Germany, cost-effectiveness, price cuts, prices
German Health Minister Philipp Rösler wants to break pharma’s ‘monopolistic hold’ over the country by introducing price limits on new …
Five-year cardiovascular study planned for Onglyza
March 10, 2010Research and Development, Sales and Marketing DPP-4, Onglyza, diabetes
Bristol-Myers Squibb and AstraZeneca are to embark on a five-year study of Onglyza in type II diabetes patients who may …
Abbott boosts pipeline with biotech acquisition
March 10, 2010Research and Development, Sales and Marketing Abbott, Facet Biotech, daclizumab, volociximab
Abbott is to acquire US company Facet Biotech in a $450 million deal that will boost its oncology and immunology …
GSK Italy workers protest site closure
March 10, 2010Research and Development GlaxoSmithKline, Italy, job cuts
Workers at a GlaxoSmithKline R&D facility in Verona, Italy, have taken to the streets to protest a decision to close …
Eusa Pharma appoints Iain McGill
March 10, 2010Sales and Marketing Eusa Pharma, appointment, sales and marketing
Iain McGill has joined specialty company Eusa Pharma as international and European president. He moves to Eusa from Wyeth Pharmaceutical, …
Pharma manufacturing news in brief
March 10, 2010Manufacturing and Production Atacama Labs, Dishman, Excella, Mentor Worldwide, Next Pharma, SAFC Pharma, Stirling Products, Strides Arcolab, Watson Pharma, undefined
A round-up of pharma manufacturing developments from Strides Arcolab, Stirling Products, NextPharma, Atacama Labs, Excella, Dishman, SAFC Pharma, Watson Pharmaceutical …
Sanofi and Merck to merge animal health businesses
March 9, 2010Sales and Marketing Merck, Sanofi, animal health
Sanofi-Aventis and Merck have announced a joint venture, bringing together their animal health businesses Merial and Intervet/Schering-Plough. The company’s say …
Recentin disappoints in colorectal cancer
March 9, 2010Research and Development AZ, Cancer, Recentin, colorectal cancer
AstraZeneca’s developmental oncology drug Recentin has failed to meet its primary endpoint in a phase II/III study. The once-daily oral …
Pfizer and King’s to collaborate on pain research
March 9, 2010Research and Development King's, Pfizer, UK
Pfizer has partnered with King’s College London to create an open innovation laboratory for pain research.The project will include a …
Survey backs waiting room promotion, says IDS
March 9, 2010Medical Communications disease awareness campaigns, patient information
A UK company specialising in promoting disease awareness messages to patients says a new study proves the value of its …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
